Psilocybin Use in the Autism Spectrum Disorder: A Scoping Review
Clinical Neuropharmacology September 1, 2025 Jaime Moreno‐chaparro, Gabriela Castañeda-millán, Javier Eslava‐schmalbach 3 citations
Objective: Due to the boom in the use of certain psychedelics in different neuropsychiatric conditions, the objective was to synthesize the available information on the use of psilocybin (a psychedelic) in the population with autism spectrum disorder (ASD; a developmental neuropsychiatric condition). Methods: Scoping review. Question framework: Population: people with ASD—Concept:...